(Reuters) – Having seen off a hostile $118 billion bid launched a year ago by U.S. rival Pfizer, Anglo-Swedish company AstraZeneca is on the move — quite literally. As of […]
Featured Posts
Pipelines Report 2023: innovation and diversification - Dealing with the seismic effects of the COVID-19 pandemic, the biopharma industry continues to break new ground during a transformative era of product innovation.ALISO VIEJO, Calif., April 15, 2015 /PRNewswire/ — Avanir Pharmaceuticals, Inc. today announced that data highlighting its central nervous system (CNS) therapeutics franchise, including data from the Phase 2 study […]
CRANBURY, N.J., April 15, 2015 /PRNewswire/ — Oncobiologics, Inc., a biotherapeutics company focused on developing and commercializing biosimilars, today announced that clinical development for ONS-1045, an Avastin®/bevacizumab biosimilar candidate, is underway […]
Traumatic events during childhood may increase kids’ risk of developing type 1 diabetes, a Swedish study suggests. The researchers questioned more than 10,000 families and found that children who experienced […]
The Pfizer logo is seen at their world headquarters in New York April 28, 2014. Reuters/Andrew Kelly Pfizer Inc said on Wednesday the first formal late-stage trial of its approved […]
COPENHAGEN, Denmark–(BUSINESS WIRE)–Today, ReSound introduced the first hearing aid app designed specifically for Apple Watch. Available immediately to Apple Watch wearers, the ReSound Smart™ app for Apple Watch offers a new, streamlined user experience, allowing […]
Medical Marijuana Extract Curbs Seizure Frequency In Early Trial Of Epilepsy Patients Epilepsy Researchers Hope to Replicate Promising Cannabidiol Findings in Randomized Controlled Studies A new study led by epilepsy […]
Reuters Health | Tue Apr 14, 2015 5:22pm EDT BY BEN GRUBER BERKELEY, CALIFORNIA – Bioengineers in California have developed a system that allows human heart cells to function outside the body, a […]
4/15/2015 8:43:44 AM Pfizer Announces PALOMA-3 Trial For IBRANCE® (Palbociclib) Stopped Early Due To Efficacy Seen In Patients With HR+, HER2- Metastatic Breast Cancer Whose Disease Has Progressed Following Endocrine […]
A new study shows that after a divorce people have an increased lifetime risk for heart attacks (myocardial infarction). Although previous studies have found that MIs occur more frequently in […]